Estrategia del fondo
The Sub-Fund aims at capital appreciation over the medium to long-term while controlling the risks related to the assets classes by investing mainly in a selected portfolio denominated in U.S Dollars of ETFs, ETNs, equities, VIX futures, options on ETFs, options on ETNs, bonds and debt securities and instruments of all types. By analysing implied and historical volatility, the Fund is creating value through different strategies among investing mainly in volatility indices. Whereby the Sub-Fund can also go into short positions of those indices using only derivatives.
Evolución
Comisiones
Rentabilidades
Detalles del fondo
Distribución Geográfica
Distribución de cartera en las distintas regiones geográficas.
| Estados Unidos de América | 93,23% | |
| Reino Unido | 14,96% | |
| Alemania | 4,12% | |
| Dinamarca | 2,33% | |
| Irlanda | 1,67% | |
| China | 1,33% |
Por inversiones
Distribución de las inversiones de este fondo.
| Scpharmaceuticals Inc Ord | 11,59% |
| Verona Pharma Adr | 8,14% |
| Concert Pharmaceuticals Inc Ord | 7,78% |
| Synlogic Inc Ord | 7,72% |
| Protara Therapeutics Inc Ord | 7,38% |
| Astria Therapeutics Inc Ord | 6,88% |
| Atai Life Sciences Nv Ord | 4,12% |
| Olema Pharmaceuticals Inc Ord | 3,79% |
| Nautilus Biotechnology Inc Ord | 3,76% |
| Orchard Therapeutics Plc Dr | 3,68% |
Por sectores
Distribución de las posiciones de este fondo según el sector al que corresponden.
| Healthcare | 117,64% |
